• 3
    Haplo
    Score
  • 0
    Triplo
    Score

Gene Facts External Data Attribution

HGNC Symbol
ATP7A (HGNC:869) HGNC Entrez Ensembl OMIM UCSC Uniprot GeneReviews LOVD LSDB ClinVar
HGNC Name
ATPase copper transporting alpha
Gene type
protein-coding gene
Locus type
gene with protein product
Previous symbols
MNK
Alias symbols
No aliases found
%HI
30.07(Read more about the DECIPHER Haploinsufficiency Index)
pLI
1(Read more about gnomAD pLI score)
LOEUF
0.22(Read more about gnomAD LOEUF score)
Cytoband
Xq21.1
Genomic Coordinates
GRCh37/hg19: chrX:77166190-77305892 NCBI Ensembl UCSC
GRCh38/hg38: chrX:77910693-78050395 NCBI Ensembl UCSC
MANE Select Transcript
NM_000052.7 ENST00000341514.11 (Read more about MANE Select)
Function
ATP-driven copper (Cu(+)) ion pump that plays an important role in intracellular copper ion homeostasis (PubMed:10419525, PubMed:11092760, PubMed:28389643). Within a catalytic cycle, acquires Cu(+) ion from donor protein on the cytoplasmic side of the membrane and delivers it to acceptor protein on the lumenal side. The transfer of Cu(+) ion across the membrane is coupled to ATP hydrolysis and is associated with a transient phosphorylation that shifts the pump conformation from inward-facing to ... (Source: Uniprot)

Dosage Sensitivity Summary (Gene)

Dosage ID:
ISCA-27820
ClinGen Curation ID:
CCID:006717
Curation Status:
Complete
Issue Type:
Dosage Curation - Gene
Haploinsufficiency:
Sufficient Evidence for Haploinsufficiency (3)
Triplosensitivity:
No Evidence for Triplosensitivity (0)
Last Evaluated:
03/24/2021

Haploinsufficiency (HI) Score Details

HI Score:
3
HI Evidence Strength:
Sufficient Evidence for Haploinsufficiency (Disclaimer)
HI Disease:
HI Evidence:
  • PUBMED: 14635105
    Tumer et al., 2013 performed review of 274 previously published and 18 novel variants in ATP7A associated with Menkes disease or occipital horn syndrome. All variants except 89 missense variants and a single dinucleotide inversion were predicted to result in nonfunctional truncated protein or nonsense mediated decay, suggesting loss of function mechanism for these diseases. Seven chromosome abnormalities were reported, including a male with an insertional event, inherited from a mother with preferential inactivation of the affected chromosome. The remaining females with chromosome abnormalities included a female patient with mosaic Turner syndrome, and five females with X;autosome translocations in which the derivative X chromosome was preferentially active, leading to a Menkes disease phenotype.
  • PUBMED: 32994893
    Mhaske 2020 compiled reported variants in ATP7A into a comprehensive database that included 602 variants. The authors concluded that nonsense, frameshift-insertion, and deletions which are truncating and cause protein disruption typically lead to severe phenotypes.
HI Evidence Comments:
Loss of function variants in ATP7A cause ATP7A-related copper transport disorders (Menkes syndrome and occipital horn syndrome in males). Female carriers are typically asymptomatic. 15% of variants identified are partial or whole gene deletions. ATP7A-related distal motor neuropathy is caused by unique missense variants rather than loss of function variants. See GeneReviews for additional information (https://www.ncbi.nlm.nih.gov/books/NBK1413/).
NOTE:

The loss-of-function and triplosensitivity ratings for genes on the X chromosome are made in the context of a male genome to account for the effects of hemizygous duplications or nullizygous deletions. In contrast, disruption of some genes on the X chromosome causes male lethality and the ratings of dosage sensitivity instead take into account the phenotype in female individuals. Factors that may affect the severity of phenotypes associated with X-linked disorders include the presence of variable copies of the X chromosome (i.e. 47,XXY or 45,X) and skewed X-inactivation in females.

Triplosensitivity (TS) Score Details

TS Score:
0
TS Evidence Strength:
No Evidence for Triplosensitivity (Disclaimer)
NOTE:

The loss-of-function and triplosensitivity ratings for genes on the X chromosome are made in the context of a male genome to account for the effects of hemizygous duplications or nullizygous deletions. In contrast, disruption of some genes on the X chromosome causes male lethality and the ratings of dosage sensitivity instead take into account the phenotype in female individuals. Factors that may affect the severity of phenotypes associated with X-linked disorders include the presence of variable copies of the X chromosome (i.e. 47,XXY or 45,X) and skewed X-inactivation in females.

Genomic View

Select assembly: (NC_000023.10) (NC_000023.11)